Gent, Belgium · Founded 2020 · Privately Held (backing)
Developer of monoclonal antibodies designed to bring to the market cost-effective services that ultimately benefit animals, producers, and consumers. Animab is based in Gent, Belgium and was founded in 2020. Its last reported valuation was $16 million in Nov 2022. It has raised $25.4 million.
Last reported valuation
$16.0M
Oct 2026
Priced at
—
Total raised
$25.4M
Last round
—
Cap table — not yet on record
Animab's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Animab with a free account
·Watch Animab: the Monday email on marks, rounds and moves
